社区获得性细菌性肺炎-话题@MedSci

#社区获得性细菌性肺炎#

6篇内容 | 686人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1493556, encodeId=40f6149355681, content=<a href='/topic/show?id=3bb4e4082b8' target=_blank style='color:#2F92EE;'>#社区获得性细菌性肺炎#</a>, objectTitle=Medicine (Baltimore)：来福林 vs. 莫西沙星治疗社区获得性细菌性肺炎患者的临床疗效和耐受性, objectType=article, longId=204118, objectId=286220411867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=286220411867, replyNumber=0, likeNumber=33, createdTime=2020-12-05, rootId=0, userName=hjwang82, userId=8cab9069092, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=286220411867, moduleTitle=Medicine (Baltimore)：来福林 vs. 莫西沙星治疗社区获得性细菌性肺炎患者的临床疗效和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=286220411867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493555, encodeId=c57914935553b, content=<a href='/topic/show?id=3bb4e4082b8' target=_blank style='color:#2F92EE;'>#社区获得性细菌性肺炎#</a>, objectTitle=Clin Infect Dis：来氟米林治疗社区获得性细菌性肺炎的效果不劣于莫西沙星，且耐受性良好, objectType=article, longId=201780, objectId=b102201e8073, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b102201e8073, replyNumber=0, likeNumber=33, createdTime=2020-10-08, rootId=0, userName=hjwang82, userId=8cab9069092, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b102201e8073, moduleTitle=Clin Infect Dis：来氟米林治疗社区获得性细菌性肺炎的效果不劣于莫西沙星，且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b102201e8073)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493554, encodeId=aa131493554b3, content=<a href='/topic/show?id=3bb4e4082b8' target=_blank style='color:#2F92EE;'>#社区获得性细菌性肺炎#</a>, objectTitle=中国NMPA授予Omadacycline优先审查：治疗社区获得性细菌性肺炎（CABP）等, objectType=article, longId=193655, objectId=d3a919365588, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a919365588, replyNumber=0, likeNumber=34, createdTime=2020-05-09, rootId=0, userName=hjwang82, userId=8cab9069092, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a919365588, moduleTitle=中国NMPA授予Omadacycline优先审查：治疗社区获得性细菌性肺炎（CABP）等, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a919365588)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493553, encodeId=320b149355384, content=<a href='/topic/show?id=3bb4e4082b8' target=_blank style='color:#2F92EE;'>#社区获得性细菌性肺炎#</a>, objectTitle=关于《社区获得性细菌性肺炎抗菌药物研发临床试验技术指导原则》和《急性细菌性皮肤与皮肤结构感染抗菌药物研发临床试验技术指导原则》征求意见的通知, objectType=article, longId=190910, objectId=dce919091038, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dce919091038, replyNumber=0, likeNumber=32, createdTime=2020-03-28, rootId=0, userName=hjwang82, userId=8cab9069092, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dce919091038, moduleTitle=关于《社区获得性细菌性肺炎抗菌药物研发临床试验技术指导原则》和《急性细菌性皮肤与皮肤结构感染抗菌药物研发临床试验技术指导原则》征求意见的通知, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dce919091038)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493552, encodeId=802414935527c, content=<a href='/topic/show?id=3bb4e4082b8' target=_blank style='color:#2F92EE;'>#社区获得性细菌性肺炎#</a>, objectTitle=FDA接受Lefamulin治疗成人社区获得性细菌性肺炎的新药申请, objectType=article, longId=160894, objectId=0a9b1608940f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a9b1608940f, replyNumber=0, likeNumber=38, createdTime=2019-02-25, rootId=0, userName=hjwang82, userId=8cab9069092, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a9b1608940f, moduleTitle=FDA接受Lefamulin治疗成人社区获得性细菌性肺炎的新药申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a9b1608940f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493551, encodeId=67621493551c6, content=<a href='/topic/show?id=3bb4e4082b8' target=_blank style='color:#2F92EE;'>#社区获得性细菌性肺炎#</a>, objectTitle=NEJM：Omadacycline治疗社区获得性细菌性肺炎, objectType=article, longId=159830, objectId=f247159830a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f247159830a2, replyNumber=0, likeNumber=36, createdTime=2019-02-14, rootId=0, userName=hjwang82, userId=8cab9069092, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f247159830a2, moduleTitle=NEJM：Omadacycline治疗社区获得性细菌性肺炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f247159830a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

社区获得性细菌性肺炎

2020-05-29

hjwang82 (审核中...)

前往app查看评论内容

#社区获得性细菌性肺炎#

Medicine (Baltimore)：来福林 vs. 莫西沙星治疗社区获得性细菌性肺炎患者的临床疗效和耐受性

2020-12-05

hjwang82 (审核中...)

前往app查看评论内容

#社区获得性细菌性肺炎#

Clin Infect Dis：来氟米林治疗社区获得性细菌性肺炎的效果不劣于莫西沙星，且耐受性良好

2020-10-08

hjwang82 (审核中...)

前往app查看评论内容

#社区获得性细菌性肺炎#

中国NMPA授予Omadacycline优先审查：治疗社区获得性细菌性肺炎（CABP）等

2020-05-09

hjwang82 (审核中...)

前往app查看评论内容

#社区获得性细菌性肺炎#

关于《社区获得性细菌性肺炎抗菌药物研发临床试验技术指导原则》和《急性细菌性皮肤与皮肤结构感染抗菌药物研发临床试验技术指导原则》征求意见的通知

2020-03-28

hjwang82 (审核中...)

前往app查看评论内容

#社区获得性细菌性肺炎#

FDA接受Lefamulin治疗成人社区获得性细菌性肺炎的新药申请

2019-02-25

hjwang82 (审核中...)

前往app查看评论内容

#社区获得性细菌性肺炎#

NEJM：Omadacycline治疗社区获得性细菌性肺炎

2019-02-14

科室
- - 订阅+
  - 更多科室
工具
服务